Cargando…
Corrigendum to: Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010260/ https://www.ncbi.nlm.nih.gov/pubmed/35235254 http://dx.doi.org/10.1111/cts.13234 |
Ejemplares similares
-
Corrigendum to: Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
Publicado: (2023) -
Propsective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function
por: Barreto, Jason N., et al.
Publicado: (2021) -
Corrigendum: Novel technique to suppress hydrocarbon contamination for high accuracy determination of carbon content in steel by FE-EPMA
por: Yamashita, Takako, et al.
Publicado: (2016) -
Corrigendum: 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function
por: Gorski, Mathias, et al.
Publicado: (2017) -
Corrigendum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
Publicado: (2021)